These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4908621)

  • 1. Rationale for the selection of chemotherapeutic agents.
    Hryniuk WM; Bertino JR
    Adv Intern Med; 1969; 15():267-97. PubMed ID: 4908621
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin, chemotherapy, and the mechanisms of malignancy: the design and the demise of cancer.
    Ayre SG; Garcia y Bellon DP; Garcia DP
    Med Hypotheses; 2000 Oct; 55(4):330-4. PubMed ID: 11000062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.
    Drummond DC; Meyer O; Hong K; Kirpotin DB; Papahadjopoulos D
    Pharmacol Rev; 1999 Dec; 51(4):691-743. PubMed ID: 10581328
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modern methods of therapeutic management of malignant proliferative disorders].
    Sroczyński J
    Wiad Lek; 1974 Nov; 27(22):1977-83. PubMed ID: 4613011
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indication for neoplasm chemotherapy and administration of antineoplastic agents].
    Hiraki K; Kimura I
    Naika; 1970 Jun; 25(6):1163-9. PubMed ID: 5431259
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antitumoral chemotherapeutic agents (with special reference to the pediatric age)].
    Lanza I
    Minerva Pediatr; 1967 Oct; 19(42):1861-96. PubMed ID: 5606238
    [No Abstract]   [Full Text] [Related]  

  • 7. [Polychemotherapy of tumors and therapeutic synergism].
    Stukov AN
    Vopr Onkol; 1979; 25(9):91-6. PubMed ID: 483726
    [No Abstract]   [Full Text] [Related]  

  • 8. Are targeted therapies really targeted?
    Schilsky RL
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):722-3. PubMed ID: 16258475
    [No Abstract]   [Full Text] [Related]  

  • 9. [Developments in chemotherapy; cytostatic agents with an increased specificity and other forms of administering cytotoxic antineoplastic agents].
    Eskens FA; de Jonge MJ; Verweij J
    Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2208-13. PubMed ID: 11757242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of mathematical modelling for calculating the optimal plan for administration of the antineoplastic agent thiophosphamide].
    Borisova OV; Korol' VI; Kulik GI; Petunin IuI; Sosnovskiĭ AA; Likhovid AP
    Dokl Akad Nauk SSSR; 1992; 322(2):410-4. PubMed ID: 1600860
    [No Abstract]   [Full Text] [Related]  

  • 11. Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies.
    Plunkett W; Gandhi V; Huang P; Robertson LE; Yang LY; Gregoire V; Estey E; Keating MJ
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):2-12. PubMed ID: 8235690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth kinetics of minimal tumour masses: implications for rational chemotherapy.
    Pileri A; Boccadoro M; Mandelli F; Amadori S
    Haematologica; 1981 Oct; 66(5):545-53. PubMed ID: 6796464
    [No Abstract]   [Full Text] [Related]  

  • 13. [Potentiation of the effects of antineoplastic agents].
    Wad T; Oara H
    Gan No Rinsho; 1971 Mar; 17(3):173-7. PubMed ID: 4926146
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined drug therapy and its significance].
    Ota K
    Nihon Rinsho; 1969 Jun; 27(6):1571-7. PubMed ID: 5816826
    [No Abstract]   [Full Text] [Related]  

  • 15. [Developments and problems of cytostatic chemotherapy].
    Gross R
    Internist (Berl); 1971; 12():Suppl 1:109-15. PubMed ID: 4944099
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanisms of action of drug therapy of cancer].
    García G
    Gac Med Mex; 1972 Feb; 103(2):129-45. PubMed ID: 5022797
    [No Abstract]   [Full Text] [Related]  

  • 17. Dendrimers as carriers for delivery of chemotherapeutic agents.
    Medina SH; El-Sayed ME
    Chem Rev; 2009 Jul; 109(7):3141-57. PubMed ID: 19534493
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimal chemotherapy regimens: influence of tumours on normal cells and several toxicity constraints.
    Matveev AS; Savkin AV
    IMA J Math Appl Med Biol; 2001 Mar; 18(1):25-40. PubMed ID: 11339336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined anti-proliferative and anti-angiogenic strategies for cancer.
    Bar J; Onn A
    Expert Opin Pharmacother; 2008 Apr; 9(5):701-15. PubMed ID: 18345949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oxaliplatin: perspectives and future developments].
    Marty M; Cottu PH; Lerebours F; Bedairia N; Hocini H; Espié M
    Bull Cancer; 2001 Aug; 88 Spec No():S5-8. PubMed ID: 11567907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.